TYPE 1 DIABETES MELLITUS
Clinical trials for TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Common drug may slow eye damage in type 1 diabetes
Disease control OngoingThis study tests whether a daily pill called fenofibrate can slow or prevent worsening of diabetic eye disease (retinopathy) in adults with type 1 diabetes. About 412 participants with early eye changes are taking either the drug or a placebo for several years. The goal is to see…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Islet transplant breakthrough: could free type 1 diabetics from insulin shots?
Disease control OngoingThis phase 3 trial tests whether transplanting insulin-making cells (islets) from donors can help people with type 1 diabetes achieve near-normal blood sugar without dangerous lows. 21 adults with severe hypoglycemia episodes received the transplant plus lifelong immune-suppressi…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: CellTrans Inc. • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
Can two immune drugs slow type 1 diabetes progression?
Disease control OngoingThis study tests whether giving two immune-modulating drugs (rituximab followed by abatacept) can better preserve the body's ability to produce insulin in people newly diagnosed with type 1 diabetes, compared to rituximab alone. About 74 participants aged 8 to 45 will be followed…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Could a custom vaccine help the body protect its own insulin?
Disease control OngoingThis early-phase trial tests a new vaccine made from a person's own immune cells. The goal is to teach the immune system to stop attacking the pancreas, so the body can keep making some insulin. Six adults with type 1 diabetes who use insulin and have no other diabetes complicati…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
Could probiotics help young people with type 1 diabetes?
Disease control OngoingThis study tests whether taking a probiotic supplement can lower inflammation in children and teens recently diagnosed with type 1 diabetes. The goal is to see if changing gut bacteria can slow the disease's progression. About 43 participants aged 5-17 will receive either the pro…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New shot aims to save Insulin-Making cells in type 1 diabetes
Disease control OngoingThis study tests an experimental treatment called Diamyd (retogatein) in 321 adolescents and adults recently diagnosed with type 1 diabetes who have a specific genetic marker (HLA DR3-DQ2). The goal is to see if three injections into a lymph node, along with vitamin D, can help p…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Islet transplants could free some from daily insulin shots
Disease control OngoingThis study tests whether transplanting insulin-producing cells from donors can help people with type 1 diabetes control blood sugar better and possibly stop taking insulin. Participants receive anti-rejection drugs to protect the transplanted cells and are followed for five years…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Probiotic shows promise in slowing type 1 diabetes progression
Disease control OngoingThis study tests whether a probiotic called Lactiplantibacillus plantarum 299v can reduce inflammation and help preserve the body's ability to produce insulin in people recently diagnosed with type 1 diabetes. About 60 participants aged 3 to 45 will receive either the probiotic o…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New app could make insulin dosing safer for type 1 diabetes patients
Disease control OngoingThis study tests whether a smartphone app called Diabetes M helps people with type 1 diabetes calculate their insulin doses more accurately than their usual method. Thirty adults will use the app for two weeks and compare their blood sugar control to two weeks without it. The goa…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Medical University of Sofia • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Smart pump trial aims to tame tough diabetes cases
Disease control OngoingThis study tests whether a hybrid closed-loop insulin pump system (mylife CamAPS FX) can improve blood sugar control and quality of life in 30 adults with type 1 diabetes who have chronically high blood sugar (HbA1c ≥ 9%) and psychological challenges. Participants are randomly as…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Jerzy Hohendorff • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New drug aims to keep insulin cells working longer in type 1 diabetes
Disease control OngoingThis study tests a new drug called brivekimig in people recently diagnosed with type 1 diabetes. The goal is to see if it can help preserve the body's ability to make some insulin, reducing the need for injected insulin. About 84 adults and adolescents will receive either the dru…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Implantable 'Cell Pouch' could free diabetics from insulin shots?
Disease control OngoingThis study tests a device called the Cell Pouch, which is implanted in the abdomen to house insulin-producing cells for people with Type 1 Diabetes who have dangerous low blood sugar episodes. The goal is to see if the device is safe and can help the cells survive long-term, pote…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: Sernova Biotherapeutics Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Massage and yoga battle to lower Kids' blood sugar
Disease control OngoingThis study looks at whether Swedish massage or yoga can help lower blood sugar levels in children aged 6 to 12 with type 1 diabetes. Both techniques are relaxing and may reduce stress, which can help control blood sugar. The study involves 50 children from Cairo who do not have o…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Al-Zaytoonah University of Jordan • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
New app aims to make exercise safer for type 1 diabetes patients
Symptom relief ENROLLING_BY_INVITATIONThis study tests a smartphone app called PACTAID in 20 adults with type 1 diabetes who use automated insulin pumps. The app helps manage blood sugar levels during and after exercise. Researchers want to see if the app improves glucose control and heart health.
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 05:58 UTC
-
Diabetes and dad bod: could weight loss rewrite sperm code?
Knowledge-focused OngoingThis study looks at whether improving metabolic health through a 3-month lifestyle or blood sugar program can change epigenetic marks in the sperm of overweight men with type 1 or type 2 diabetes. Researchers will measure sperm concentration and DNA methylation patterns before an…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Decades-Long diabetes study reveals lasting effects of early treatment
Knowledge-focused OngoingThis study follows over 1,400 people with type 1 diabetes who were part of an earlier trial. Researchers are tracking how early intensive blood sugar control affects long-term health, including eye, kidney, nerve, and heart problems. The goal is to understand risk factors for com…
Matched conditions: TYPE 1 DIABETES MELLITUS
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC